Arkolith/Insider Trading/CATX/Form 4

Williamson Robert F III

DirectorPerspective Therapeutics, Inc. (CATX) · full profile →Form 4 · filed Apr 1, 2025
Net Buying
Open-Market Buys
$132K
Open-Market Sells
$0
Net Open-Market Flow
$132K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2025Buy(P)38K$2.14$82K109K
Mar 28, 2025Buy(P)22K$2.27$50K71K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-048698) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML